Journal Club
2026.10.20
Somatic epimutations cap genetic determinism in the human diploid chromatin epigenome
Cell
2026.10.13
Copper ion-induced MYH9 polymerization executes cuproptosis
Cell
2026.09.29
Iron-addicted colorectal cancers exploit heme-complex II axis to resist oxidative cell death
Cell Metabolism
2026.09.22
Hypertranscription caused by p53 deficiency triggers nucleotide insufficiency that induces replication stress and genomic instability
Molecular Cell
2026.09.08
IGF2BP1 phosphorylation in the disordered linkers regulates ribonucleoprotein condensate formation and RNA metabolism
Nature Communications
2026.09.01
Deep CRISPR mutagenesis characterizes the functional diversity of TP53 mutations
Nature Genetics
2026.08.25
ZFP36L2 orchestrates stress-adaptive plasticity in regeneration and cancer
Nature
2026.08.18
mRNA 3′ UTRs chaperone intrinsically disordered regions to control protein activity
Cell
2026.08.11
Cuproptosis-immunity crosstalk informs strategy to overcome immunotherapy resistance
Cell
2026.08.04
Targeting cancer-specific mutations with RNA-triggered chromatin shredding
Nature
2026.07.28
RNA exonuclease REXO4 resolves m6A-marked R-loops and suppresses anti-tumor immunity
Molecular Cell
2026.07.21
m6A modification suppresses innate antitumour immunity in colorectal cancer by limiting alu-derived dsRNA accumulation
Nature Communications
2026.07.14
p53 induces circFRMD4A to suppress cancer development through glycolytic reprogramming and cuproptosis
Molecular Cell
2026.06.30
METTL3-mediated m6A modification of CACNA1E promotes osteosarcoma progression and chemoresistance by enhancing WNT7B-mediated Ca2+ signaling
Molecular Cancer
2026.06.23
USP5 stabilizes YTHDF1 to control cancer immune surveillance through mTORC1- mediated phosphorylation
Nature Communications
2026.06.16
Reduced YTHDF2 inhibits PD-L1 expression by stabilizing m6A-containing SPOP mRNA in colorectal cancer
Cell Death & Disease
2026.06.09
Cancer-specific CTCF binding facilitates oncogenic transcriptional dysregulation
Genome Biology
2026.06.02
Profiling of RNA-binding protein binding sites by in situ reverse transcription-based sequencing
Nature Methods
2026.05.19
HSF1 and YTHDC1 enhance DNA repair under heat stress by promoting repair-associated gene expression
Nucleic Acids Research
2026.05.12
BE screen reveals METTL3 S2 dephosphorylation sensitizes gastric cancer cells to oxaliplatin by interfering METTL3-eIF3H interaction
Science Advances
2026.04.21
Targeting WEE1 in ARID1A/TP53 Concurrent Mutant Colorectal Cancer by Exploiting R-Loop Accumulation and DNA Repair Deficiencies
Advanced Science
2026.04.14
The METTL3-YTHDC1 axis mediates architectural RNA m6A modification to modulate the integrity of chromatin TADs in MLLr+AML genome
Molecular Cancer
2026.04.07
RNA polymerase II partitioning is a shared feature of diverse oncofusion condensates
Cell
2026.03.30
Cancer Cell-Secreted miR-33a Reduces Stress Granule Formation by Targeting Polyamine Metabolism in Stroma to Promote Tumourigenesis
Journal of Extracellular Vesicles
2026.03.24
Smarca4 Inactivation Promotes Lineage-Specific Transformation and Early Metastatic Features in the Lung
Cancer Discovery
2026.03.17
N6-adenosine methylation enhances nuclear mRNA export through METTL3 and NUP93
Nature Cell Biology
2026.03.10
Targeting thymine DNA glycosylase induces synthetic lethality in p53-deficient cancers
Nature Chemical Biology
2026.03.04
METTL3-based epitranscriptomic editing screening identifies functional m6A sites in cancers
Nature Cancer
2026.02.09
Helicobacter pylori CagA elevates FTO to induce gastric cancer progression via a “hit-and-run” paradigm
Cancer Communications
2026.02.02
Repurposing clinically safe drugs for DNA repair pathway choice in CRISPR genome editing and synthetic lethality
Nature Communications
2026.01.27
Single-molecule m6A detection empowered by endogenous labeling unveils complexities across RNA isoforms
Molecular Cell
2026.01.20
METTL3-dependent m6A RNA methylation regulates transposable elements and represses human naïve pluripotency through transposable element-derived enhancers
Nucleic Acids Research
2026.01.13
Nuclear m6A modification regulates satellite transcription and chromosome segregation
Nature Chemical Biology
2026.01.07
FOCAS: Transcriptome-wide screening of individual m6A sites functionally dissects epitranscriptomic control of gene expression in cancer
Cell
2025. 12. 30
Isoform characterization of m6A in single cells identifies its role in RNA surveillance
Nature Commuications
2025. 12. 17
LL22NC03-N14H11.1 regulates the m6A modification of MYC and promotes glycolytic activity in hepatocellular carcinoma cells by inhibiting IGF2BP3 ubiquitination degradation
Journal of Experimental & Clinical Cancer Research
2025. 12. 09
Targeting the ESCRT-III component CHMP2A for noncanonical Caspase-8 activation on autophagosomal membranes
Cell Death & Differentiation
2025. 11. 30
Synthetic lethality of mRNA quality control complexes in cancer
Nature
2025. 11. 11
SRSF9 Forms Phase-Separated Condensates to Promote Ovarian Cancer Progression by Inducing RNA Alternative Splicing That Is Inhibited by m6A Modification
Cancer Research
2025. 11. 05
METTL14 Enhances Antitumor Immunity throughm6A-Dependent Loss of PD-1
Cancer Research
2025. 10. 21
YTHDF proteins and m 6 A-RNA clients undergo autophagic turnover during contact inhibition
Cell Reports
2025. 09. 23
Targeting YTHDF2 with pH-responsive siRNA nanoparticles suppresses MYC m6A modification and restores antitumor immunity in hepatocellular carcinoma
Journal of Nanobiotechnology
2025. 09. 16
SRCAP mutations drive clonal hematopoiesis through epigenetic and DNA repair dysregulation
Cell Stem Cell
2025. 09. 02
Loss of YTHDF2 enhances Th9 programming and CAR-Th9 cell antitumor efficacy
Nature Immunology
2025. 08. 05
TM4SF1-AS1 inhibits apoptosis by promoting stress granule formation in cancer cells
Cell Death & Discovery
2025. 07. 30
Nuclear accumulation of YTHDF1 regulates mRNA splicing in the DNA damage response
Science Advances
2025. 07. 22
SWI/SNF as mechanoregulated inhibitor of YAP/TAZ
Nature
2025. 07. 15
A single-cell atlas of glioblastoma evolution under therapy reveals cell-intrinsic and cell-extrinsic therapeutic targets
Nature Cancer
2025. 07. 01
tRNA modifications tune m6A-dependent mRNA decay
Cell
2025. 06. 24
The RNA-stability-independent role of the RNA m6A reader YTHDF2 in promoting protein translation to confer tumor chemotherapy resistance
Molecular Cell
2025. 06. 17
SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway
Cancer Letters
2025. 06. 10
m6A alters ribosome dynamics to initiate mRNA degradation
Cell
2025. 05. 27
Cancer mutations rewire the RNA methylation specificity of METTL3-METTL14
Science Advances
2025. 05. 19
Suppression of stress granule formation is a vulnerability imposed by mutant p53
Nature Commuications
2025. 04. 20
Poly-(ADP-ribose) serves as a scaffold for the methyltransferase METTL3 / 14 complex in the DNA damage response
Nucleic Acids Research
2025. 04. 09
Spatial control of m6A deposition on enhancer andpromoter RNAs through co-acetylation of METTL3and H3K27 on chromatin
Molecular Cell
2025. 04. 01
The coevolution of the genome and epigenome in colorectal cancer
Nature
2025. 03. 24
IGF2BP3 promotes mRNA degradation through internal m7G modification
Nature Commuications
2025. 03. 17
METTL17 coordinates ferroptosis and tumorigenesis by regulating mitochondrial translation in colorectal cancer
Redox Biology
2025. 03. 11
The RNA m6A Reader YTHDF2 MaintainsOncogene Expression and Is a TargetableDependency in Glioblastoma Stem Cells
Cancer Discovery
2025. 03. 04
Synonymous mutations promote tumorigenesis bydisrupting m6A-dependent mRNA metabolism
Cell
2025. 02. 11
Methionine-driven YTHDF1 expression facilitates bladder cancer progression by attenuating RIG-I-modulated immune responses and enhancing the eIF5B-PD-L1 axis
Cell Death & Differentiation
2025. 02. 25
Fine-tuning of gene expression through the Mettl3-Mettl14-Dnmt1 axis controls ESC differentiation
Cell
2025. 02. 18
Single-nucleus multiomic mapping of m6A methylomes and transcriptomes in native populations of cells with sn-m6A-CT
Molecular Cell
2025. 02. 04
ATXN2-mediated translation of TNFR1promotes esophageal squamous cellcarcinoma via m6A-dependent manner
Molecular Therapy
2025. 01. 21
Stress Granules Determine the Development of Obesity-Associated Pancreatic Cancer
Cancer Discovery
2025. 01. 14
Intrinsically disordered region-mediated condensation of IFN-inducible SCOTIN_SHISA-5 inhibits ER-to-Golgi vesicle transport
Developmental Cell
2025. 01. 06
QKI shuttles internal m7G-modified transcripts into stress granules and modulates mRNA metabolism
Cell
2024. 12. 31
Nuclear retention coupled with sequential polyadenylation dictates post-transcriptional m6A modification in the nucleus
Molecular Cell
2024. 12. 24
Loss-of-Function but Not Gain-of-Function Properties of Mutant TP53 Are Critical for the Proliferation, Survival, and Metastasis of a Broad Range of Cancer Cells
Cancer Discovery
2024. 12. 17
m6A sites in the coding region trigger translation-dependent mRNA decay
Molecular Cell
2024. 12. 10
DNA damage induces p53-independent apoptosis through ribosome stalling
Science
2024. 12. 04
STAG2 mutations alter CTCF-anchored loop extrusion, reduce cis-regulatory interactions and EWSR1-FLI1 activity in Ewing sarcoma
Cancer Cell
2024. 11. 19
The N6-methyladenosine epitranscriptomic landscape of lung adenocarcinoma
Cancer Discovery
2024. 11. 05
m6A-modified cenRNA stabilizes CENPA to ensure centromere integrity in cancer cells
Cell
2024. 10. 29
Inhibition of the MYC-regulated glutaminase metabolic axis is an effective synthetic lethal approach for treating chemoresistant OC
Cancer Research
2024. 10. 22
DNA damage promotes TMPRSS2-ERG oncoprotein destruction and prostate cancer suppression via signaling converged by GSK3b and WEE1
Molecular Cell
2024. 10. 15
BNIP3 phosphorylation by JNK1/2 promotes mitophagy via enhancing its stability under hypoxia
Cell Death & Disease
2024. 09. 24
m6A-dependent glycolysis enhances colorectal cancer progression
Molecular Cell
2024. 08. 13
METTL1/WDR4-mediated tRNA m7G modification and mRNA translation control promote oncogenesis and doxorubicin resistance
Oncogene
2024. 07. 30
HEATR1 deficiency promotes pancreatic cancer proliferation and gemcitabine resistance by up-regulating Nrf2 signaling
Redox Biology
2024. 07. 23
A lncRNA from the FTO locus acts as a suppressor of the m6A writer complex and p53 tumor suppression signaling
Molecular Cell
2024. 07. 16
m6A governs length-dependent enrichment of mRNAs in stress granules
Nature Structural & Molecular Biology
2024. 07. 02
The tumor-intrinsic role of the m6A reader YTHDF2 in regulating immune evasion
Science Immunology
2024. 06. 25
Prediction of m6A and m6C at single-molecule resolution reveals a transcriptome-wide co-occurrence of RNA modifications
Nature Communications
2024. 05. 21
Single-molecule epitranscriptomic analysis of full-length HIV-1 RNAs reveals functional roles of site-specific m6As
Nature Microbiology
2024. 05. 07
Structural and functional properties of mSWI/SNF chromatin remodeling complexes revealed through single-cell perturbation screens
Molecular Cell
2024. 04. 30
Low RNA stability signifies increased post-transcriptional regulation of cell identity genes
Nucleic Acids Research
2024. 04. 24
Von Hippel Lindau tumor suppressor controls m6A-dependent gene expression in renal tumorigenesis
The Journal of Clinical Investigation
2024. 04. 16
DDX21 mediates co-transcriptional RNA m6A modification to promote transcription termination and genome stability
Molecular Cell
2024. 04. 09
A circular RNA activated by TGFb promotes tumor metastasis through enhancing IGF2BP3-mediated PDPN mRNA stability
Nature Communications
2024. 04. 02
Transcriptional control of leukemogenesis by the chromatin reader SGF29
Blood
2024. 03. 26
METTL3 drives telomere targeting of TERRA lncRNA through m6A-dependent R-loop formation: a therapeutic target for ALT-positive neuroblastoma
Nucleic Acids Research
2024. 03. 20
Targeting NURP1-dependent stress granules formation to induce synthetic lethality in KrasG12D-driven tumors
EMBO Molecular Medicine
2024. 03. 13
The ARID1A-METTL3-m6A axis ensures effective RNase H1-mediated resolution of R-loops and genome stability
Cell Reports
2024. 03. 05
PARP1 modulates METTL3 promoter chromatin accessibility and associated LPAR5 RNA m6A methylation to control cancer cell radiosensitivity
Molecular Therapy
2024. 02. 27
A deregulated m6A writer complex axis driven by BRD4 confers and epitranscriptomic vulnerability in combined DNA repair-targeted therapy
PNAS
2024. 02. 20
Receptor-driven ERK pulses reconfigure MAPK signaling and enable persistence of drug-adapted BRAF-mutant melanoma cells
Cell Systems
2024. 02. 13
YTHDF2 is a therapeutic target for HCC by suppressing immune evasion and angiogenesis through ETV5/PD-L1/VEGFA axis
Advanced Science
2024. 02. 06
The chromatin remodeler CHD6 promotes colorectal cancer development by regulating TMEM65-mediated mitochondrial dynamics via EGF and Wnt signaling
Cell Discovery
2024. 01. 30
EGFR promotes ALKBH5 nuclear retention to attenuate N6-methyladenosine and protect against ferroptosis in glioblastoma
Molecular Cell
2024. 01. 23
Overcoming therapeutic resistance in oncolytic herpes virotherapy by targeting IGF2BP3-induced NETosis in malignant glioma
Nature Communications
2024. 01. 08
Super-enhancer RNA m6A promotes local chromatin accessibility and oncogene transcription in pancreatic ductal adenocarcinoma
Nature Genetics
2024. 01. 02
Cooperation of chromatin remodeling SWI/SNF complex and pioneer factor AP-1 shapes 3D enhancer landscapes
Nature Structural & Molecular Biology
2023. 12. 18
m6A modification negatively regulates translation by switching mRNA from polysome to P-body via IGF2BP3
Molecular Cell
2023. 12. 11
p53 wild-type colorectal cancer cells that expres a fetal gene signature are associated with metastasis and poor prognosis
Nature Communications
2023. 12. 04
Targeting glutamine metabolism slows soft tissue sarcoma growth
Nature Communications
2023. 11. 27
Splicing factor BUD31 promotes ovarian cancer progression through sustaining the expression of anti-apoptotic BCL2L12
Nature Communications
2023. 11. 13
Lineage plasticity in prostate cancer depends on JAK/STAT inflammatory signaling
Science
2023. 10. 30
Rewired m6A epitranscriptomic networks link mutant p53 to neoplastic transformation
Nature Communications
2023. 10. 23
CSTF2 mediated mRNA N6-methyladenosine modification drives pancreatic ductal adenocarcinoma m6A subtypes
Nature Communications
2023. 10. 16
METTL14 is a chromatin regulator independent of its RNA N6-methyladenosine methyltransferase activity
Protein & Cell
2023. 09. 25
RBFOX2 recognizes N6-methyladenosine to suppress transcription and block myeloid leukaemia differentiation
Nature Cell Biology
2023. 09. 18
METTL3 inhibition induced by M2 macrophage-derived extracellular vesicles drives anti-PD-1 therapy resistance via M6A-CD70-mediated immune suppression in thyroid cancer
Cell Death & Differentiation
2023. 09. 11
N6-Methyladenosine-modified circSAV1 triggers ferroptosis in COPD through recruiting YTHDF1 to facilitate the translation of IREB2
Cell Death & Differentiation
2023. 08. 30
Inhibition of METTL3 results in a cell-intrinsic interferon response that enhances anti-tumour immunity
Cancer Discovery
2023.08.23
The m6A reader IMP2 directs autoimmune inflammation through an IL-17– and TNF-dependent C/EBP transcription factor axis
Science Immunology
2023.08.16
Targeting Anthrax Toxin Receptor 2 Ameliorates Endometriosis Progression
Theranostics
2023.08.09
The ubiquitin ligase TRIM21 regulates mutant p53 accumulation and gain of function in cancer
The Journal of Clinical Investigation
2023.08.02
GRIN2D knockdown suppresses the progression of lung adenocarcinoma by regulating the E2F signalling pathway
Cellular Signaling
2023.07.18
Targeting the mevalonate pathway suppresses ARID1A-inactivated cancers by promoting pyroptosis
Cancer Cell
2023.07.05
METTL14 regulates chromatin bivalent domains in mouse embryonic stem cells
Cell Reports
2023.06.27
YTHDF2 inhibition potentiates radiotherapy antitumor efficacy
Cancer Cell
Tumor-intrinsic YTHDF1 drives immune evasion and resistance to immune checkpoint inhibitors via promoting MHC-I degradation
Nature Communications
RBM33 is a unique m6 A RNA-binding protein that regulates ALKBH5 demethylase activity and substrate selectivity
Molecular Cell
Multiomic Analysis of Lung Tumors Defines Pathways Activated in Neuroendocrine Transformation
Cancer Discovery
Neddylation is essential for b-catenin degradation in Wnt signaling pathway
Cell Reports
Synthetic Essentiality of Tryptophan 2,3-Dioxygenase 2 in APC-Mutated Colorectal Cancer
Cancer Discovery
2023.04.05
A Prion-like Domain in Transcription Factor EBF1 Promotes Phase Separation and Enables B Cell Programming of Progenitor Chromatin
Immunity
2023.03.28
METTL3 protects METTL14 from STUB1-mediated degradation to maintain m6 A homeostasis
EMBO Rep
2023. 03. 14
Targeting m6A reader YTHDF1 augments antitumour immunity and boosts anti-PD-1 efficacy in colorectal cancer
Gut
2023. 03. 08
Exon architecture controls mRNA m6A suppression and gene expression
Science
2023. 02. 27
Single-molecule identification of the target RNAs of different RNA binding proteins simultaneously in cells
Genes & Development
2023. 02. 14
Regulation of EZH2 by SMYD2-Mediated Lysine Methylation Is Implicated in Tumorigenesis
Cell Reports
2023. 02. 08
RING1B recruits EWSR1-FLI1 and cooperates in the remodeling of chromatin necessary for Ewing sarcoma tumorigenesis
Science Advances
2023. 01. 31
CDK7 inhibitor THZ1 enhances antiPD-1 therapy efficacy via the p38α/MYC/PD-L1 signaling in non-small cell lung cancer
Journal of Hematology & Oncology
2023. 01. 18
Different hotspot p53 mutants exert distinct phenotypes and predict outcome of colorectal cancer patients
Nature Communications
2023. 01. 10
The N6-methyladenosine methyltransferase METTL16 enables erythropoiesis through safeguarding genome integrity
Nature Communications
2023. 01. 04
A non-canonical SWI/SNF complex is a synthetic lethal target in cancers driven by BAF complex perturbation
Nature Cell Biology
2022. 12. 27
CD73 on cancer-associated fibroblasts enhanced by the A2B-mediated feedforward circuit enforces an immune checkpoint
Nature Communications
2022. 12. 20
Low expression of TRAF3IP2-AS1 promotes progression of NONO-TFE3 translocation renal cell carcinoma by stimulating N6-methyladenosine of PAR
Journal of Hematology & Oncology
2022. 11. 29
Regulation of mutant TERT by BRAF V600E/MAP kinase pathway through FOS/GABP in human cancer
Nature Communications
2022. 11. 22
METTL3 acetylation impedes cancer metastasis via fine-tuning its nuclear and cytosolic functions
Nature Communications
2022. 11. 15
Absolute quantification of single-base m6A methylation in the mammalian transcriptome using GLORI
Nature Protocols
2022. 11. 01
RAC1B modulates intestinal tumourigenesis via modulation of WNT and EGFR signalling pathways
Nature Communications
20220. 10. 25
Autophagy induction promoted by m6A reader YTHDF3 through translation upregulation of FOXO3 mRNA
Nature Communications
2022. 10. 18
Cancer-Specific Retargeting of BAF Complexes by a Prion-like Domain
Cell
2022. 10. 11
RNA m6A regulates transcription via DNA demethylation and chromatin accessibility
Nature Genetics
2022. 10. 04
Methionine deficiency facilitates antitumour immunity by altering m6A methylation of immune checkpoint transcripts
Gut
2022. 09. 27
Promoter-bound METTL3 maintains myeloid leukaemia by m6A-dependent translation control
Nature
2022. 09. 20
MEK inhibition overcomes chemoimmunotherapy resistance by inducing CXCL10 in cancer cells
Cancer Cell
2022. 09. 06
METTL3 Inhibits Antitumor Immunity by Targeting m6A-BHLHE41-CXCL1/CXCR2 Axis to Promote Colorectal Cancer
Gastroenterology
2022. 08. 31
Cell–matrix interface regulates dormancy in human colon cancer stem cells
Nature
2022. 08. 23
Anti-HIV Drug Elvitegravir Suppresses Cancer Metastasis via Increased Proteasomal Degradation of m6A Methyltransferase METTL3
Cancer Research
2022. 08. 09
METTL14-mediated epitranscriptome modification of MN1 mRNA promote tumorigenicity and all-trans-retinoic acid resistance in osteosarcoma
EBioMedicine
2022. 08. 02
METTL3/IGF2BP3 axis inhibits tumor immune surveillance by upregulating N6-methyladenosine modification of PD-L1 mRNA in breast cancer
Molecular Cancer
2022. 07. 26
Acetylation dependent translocation of EWSR1 regulates CHK2 alternative splicing in response to DNA damage
Oncogene
2022. 07. 12
PDGF signaling inhibits mitophagy in glioblastomastem cells through N6-methyladenosine
Dev Cell
2022. 07. 04
N6-methyladenosine regulated FGFR4 attenuates ferroptotic cell death in recalcitrant HER2-positive breast cancer
Nature Communications
2022. 06. 28
The Mettl3 epitranscriptomic writer amplifies p53 stress responses
Molecular Cell
2022. 06. 15
Lactylation-driven METTL3-mediated RNA m6A modification promotes immunosuppression of tumor-infiltrating myeloid cells
Molecular Cell
2022. 05. 31
A novel β-catenin/BCL9 complex inhibitor blocks oncogenic Wnt signaling and disrupts cholesterol homeostasis in colorectal cancer"
Sci Adv
2022. 03. 17
JNK Signaling Promotes Bladder Cancer Immune Escape by Regulating METTL3-Mediated m6A Modification of PD-L1 mRNA
Cancer Research
2022. 05. 10
Fusobacterium nucleatum reduces METTL3-mediated m6A modification and contributes to colorectal cancer metastasis
Nature Communications
2022. 05. 02
MAPK Signaling and Inflammation Link Melanoma Phenotype Switching to Induction of CD73 during Immunotherapy
Cancer Research
2022. 04. 26
TGFβ promotes widespread enhancer chromatin opening and operates on genomic regulatory domains
Nature Communications
2022. 04. 12
Loss of YTHDF1 in gastric tumors restores sensitivity to antitumor immunity by recruiting mature dendritic cells
Journal for ImmunoTherapy of Cancer
2022. 04. 04
Integrative clinical and molecular characterization of translocation renal cell carcinoma
Cell Reports
2022. 03. 22
Characterization of Hippo Pathway Components by Gene Inactivation
Molecular Cell
2022. 02. 15
ARID1A prevents squamous cell carcinoma initiation and chemoresistance by antagonizing pRb/E2F1/c-Myc-mediated cancer stemness
Cell Death & Differentiation
2022. 02. 08
Endogenous topoisomerase II-mediated DNA breaks drive thymic cancer predisposition linked to ATM deficiency
Nature Communications
2022. 01. 25
ARID1A deficiency weakens BRG1-RAD21 interaction that jeopardizes chromatin compactness and drives liver cancer cell metastasis
Cell Death & Disease
2022. 01. 11
Regulation of AR mRNA translation in response to acute AR pathway inhibition
Nucleic Acids Res
2022. 01. 04
METTL3-mediated m6A RNA methylation promotes the anti-tumour immunity of natural killer cells
Nat Commun
2021. 12. 29
HRD1-mediated METTL14 degradation regulates m6A mRNA modification to suppress ER proteotoxic liver disease
Mol Cell
2021. 12. 13
Gain-of-Function RHOA Mutations Promote Focal Adhesion Kinase Activation and Dependency in Diffuse Gastric Cancer
Cancer Discov
2021. 12. 06
The RNA-binding protein IGF2BP3 is critical for MLL-AF4-mediated leukemogenesis
Leukemia
2021. 11. 29
N6-methyladenosine reader IMP2 stabilizes the ZFAS1/OLA1 axis and activates the Warburg effect: implication in colorectal cancer
J Hematol Oncol
2021. 11. 15
Altered RNA Splicing by Mutant p53 Activates Oncogenic RAS Signaling in Pancreatic Cancer
Cancer Cell
2021. 11. 09
Targeting the Vulnerability of Glutathione Metabolism in ARID1A-Deficient Cancers
Cancer Cell
2021. 11. 02
N6 -methyladenosine-Mediated Upregulation of WTAPP1 Promotes WTAP Translation and Wnt Signaling to Facilitate Pancreatic Cancer Progression
Cancer Research
2021. 10. 19
N6-methyladenosine modification regulates ferroptosis through autophagy signaling pathway in hepatic stellate cells
Redox Biology
2021. 10. 12
Targeting Aurora B kinase prevents and overcomes resistance to EGFR inhibitors in lung cancer by enhancing BIM- and PUMA-mediated apoptosis
Cancer Cell
2021. 10. 05
Genome-scale CRISPR-Cas9 screen of Wnt/β-catenin signaling identifies therapeutic targets for colorectal cancer
Science Advances
2021. 09. 27
Downregulation of the FTO m6A RNA demethylase promotes EMT-mediated progression of epithelial tumors and sensitivity to Wnt inhibitors
Nature Cancer
2021. 09. 14
Enhancement of E-cadherin expression and processing and driving of cancer cell metastasis by ARID1A deficiency
Oncogene
2021. 09. 06
mTORC stimulates cell growth through SAM synthesis and m6A mRNA-dependent control of protein synthesis
Molecular Cell
